Vanquish44/Healthcare_NLP huggingface dataset:
Question: What are the treatments for Heart Failure ?
Answer: For severe heart failure, patients may require additional oxygen, a mechanical heart pump, or a heart transplant.

Topic: Heart Failure
Source: NIHSeniorHealth
Question: What is (are) Heart Failure ?
Answer: More detailed information on heart failure is available at http://www.nhlbi.nih.gov/health/dci

Topic: Heart Failure
Source: NIHSeniorHealth
Question: Who is at risk for Breast Cancer? ?
Answer: Sometimes breast cancer occurs in women who are pregnant or have just given birth. Breast cancer occurs about once in every 3,000 pregnancies. It occurs most often between the ages of 32 and 38.

Topic: Breast Cancer
Source: CancerGov
Question: What are the symptoms of Breast Cancer ?
Answer: Signs of breast cancer include a lump or change in the breast.
                    These and other signs may be caused by breast cancer or by other conditions. Check with your doctor if you have any of the following:         - A lump or thickening in or near the breast or in the underarm area.    -  A change in the size or shape of the breast.    -  A dimple or puckering in the skin of the breast.    -  A nipple turned inward into the breast.    - Fluid, other than breast milk, from the nipple, especially if it's bloody.    - Scaly, red, or swollen skin on the breast, nipple, or areola (the dark area of skin around the nipple).    - Dimples in the breast that look like the skin of an orange, called peau dorange.
                
                
                    It may be difficult to detect (find) breast cancer early in pregnant or nursing women.
                    The breasts usually get larger, tender, or lumpy in women who are pregnant, nursing, or have just given birth. This occurs because of normal hormone changes that take place during pregnancy. These changes can make small lumps difficult to detect. The breasts may also become denser. It is more difficult to detect breast cancer in women with dense breasts using mammography. Because these breast changes can delay diagnosis, breast cancer is often found at a later stage in these women.

Topic: Breast Cancer
Source: CancerGov
Question: What is the outlook for Breast Cancer ?
Answer: Certain factors affect prognosis (chance of recovery) and treatment options.The prognosis (chance of recovery) and treatment options depend on the following:         - The stage of the cancer (the size of the tumor and whether it is in the breast only or has spread to other parts of the body).    - The type of breast cancer.    - The age of the unborn baby.    - Whether there are signs or symptoms.    - The patients general health.

Topic: Breast Cancer
Source: CancerGov
Question: What is (are) Hairy Cell Leukemia ?
Answer: Key Points
                    - Hairy cell leukemia is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell).    - Leukemia may affect red blood cells, white blood cells, and platelets.    - Gender and age may affect the risk of hairy cell leukemia.     - Signs and symptoms of hairy cell leukemia include infections, tiredness, and pain below the ribs.     - Tests that examine the blood and bone marrow are used to detect (find) and diagnose hairy cell leukemia.    - Certain factors affect treatment options and prognosis (chance of recovery).
                
                
                    Hairy cell leukemia is a type of cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell).
                    Hairy cell leukemia is a cancer of the blood and bone marrow. This rare type of leukemia gets worse slowly or does not get worse at all. The disease is called hairy cell leukemia because the leukemia cells look "hairy" when viewed under a microscope.
                
                
                    Leukemia may affect red blood cells, white blood cells, and platelets.
                    Normally, the bone marrow makes blood stem cells (immature cells) that become mature blood cells over time. A blood stem cell may become a myeloid stem cell or a lymphoid stem cell.    A myeloid stem cell becomes one of three types of mature blood cells:         -  Red blood cells that carry oxygen and other substances to all tissues of the body.    -  White blood cells that fight infection and disease.    -  Platelets that form blood clots to stop bleeding.        A lymphoid stem cell becomes a lymphoblast cell and then into one of three types of lymphocytes (white blood cells):          -  B lymphocytes that make antibodies to help fight infection.    -  T lymphocytes that help B lymphocytes make antibodies to help fight infection.    -  Natural killer cells that attack cancer cells and viruses.         In hairy cell leukemia, too many blood stem cells become lymphocytes. These lymphocytes are abnormal and do not become healthy white blood cells. They are also called leukemia cells. The leukemia cells can build up in the blood and bone marrow so there is less room for healthy white blood cells, red blood cells, and platelets. This may cause infection, anemia, and easy bleeding. Some of the leukemia cells may collect in the spleen and cause it to swell.   This summary is about hairy cell leukemia. See the following PDQ summaries for information about other types of leukemia:         -  Adult Acute Lymphoblastic Leukemia Treatment.    -  Childhood Acute Lymphoblastic Leukemia Treatment.    -  Chronic Lymphocytic Leukemia Treatment.    -  Adult Acute Myeloid Leukemia Treatment.    -  Childhood Acute Myeloid Leukemia/Other Myeloid Malignancies Treatment.    -  Chronic Myelogenous Leukemia Treatment.

Topic: Hairy Cell Leukemia
Source: CancerGov
Question: Who is at risk for Hairy Cell Leukemia? ?
Answer: Gender and age may affect the risk of hairy cell leukemia. Anything that increases your chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesnt mean that you will not get cancer. Talk with your doctor if you think you may be at risk. The cause of hairy cell leukemia is unknown. It occurs more often in older men.

Topic: Hairy Cell Leukemia
Source: CancerGov
Question: What are the symptoms of Hairy Cell Leukemia ?
Answer: Signs and symptoms of hairy cell leukemia include infections, tiredness, and pain below the ribs. These and other signs and symptoms may be caused by hairy cell leukemia or by other conditions. Check with your doctor if you have any of the following:          - Weakness or feeling tired.    -  Fever or frequent infections.    - Easy bruising or bleeding.    - Shortness of breath.    - Weight loss for no known reason.    - Pain or a feeling of fullness below the ribs.    - Painless lumps in the neck, underarm, stomach, or groin.

Topic: Hairy Cell Leukemia
Source: CancerGov
Question: What is the outlook for Hairy Cell Leukemia ?
Answer: Certain factors affect treatment options and prognosis (chance of recovery). The treatment options may depend on the following:         - The number of hairy (leukemia) cells and healthy blood cells in the blood and bone marrow.    - Whether the spleen is swollen.    - Whether there are signs or symptoms of leukemia, such as infection.    - Whether the leukemia has recurred (come back) after previous treatment.        The prognosis (chance of recovery) depends on the following:         - Whether the hairy cell leukemia does not grow or grows so slowly it does not need treatment.    - Whether the hairy cell leukemia responds to treatment.        Treatment often results in a long-lasting remission (a period during which some or all of the signs and symptoms of the leukemia are gone). If the leukemia returns after it has been in remission, retreatment often causes another remission.

Topic: Hairy Cell Leukemia
Source: CancerGov
Question: What are the stages of Hairy Cell Leukemia ?
Answer: Key Points
                    - There is no standard staging system for hairy cell leukemia.
                
                
                    There is no standard staging system for hairy cell leukemia.
                    Staging is the process used to find out how far the cancer has spread. Groups are used in place of stages for hairy cell leukemia. The disease is grouped as untreated, progressive, or refractory.       Untreated hairy cell leukemia     The hairy cell leukemia is newly diagnosed and has not been treated except to relieve signs or symptoms such as weight loss and infections. In untreated hairy cell leukemia, some or all of the following conditions occur:            - Hairy (leukemia) cells are found in the blood and bone marrow.     - The number of red blood cells, white blood cells, or platelets may be lower than normal.     - The spleen may be larger than normal.                Progressive hairy cell leukemia     In progressive hairy cell leukemia, the leukemia has been treated with either chemotherapy or splenectomy (removal of the spleen) and one or both of the following conditions occur:            - There is an increase in the number of hairy cells in the blood or bone marrow.     - The number of red blood cells, white blood cells, or platelets in the blood is lower than normal.

Topic: Hairy Cell Leukemia
Source: CancerGov
Question: what research (or clinical trials) is being done for Hairy Cell Leukemia ?
Answer: New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                 
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                 
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.

Topic: Hairy Cell Leukemia
Source: CancerGov
Question: What is (are) Vulvar Cancer ?
Answer: Key Points
                    - Vulvar cancer is a rare disease in which malignant (cancer) cells form in the tissues of the vulva.    - Having vulvar intraepithelial neoplasia or HPV infection can affect the risk of vulvar cancer.    - Signs of vulvar cancer include bleeding or itching.    - Tests that examine the vulva are used to detect (find) and diagnose vulvar cancer.    - Certain factors affect prognosis (chance of recovery) and treatment options.
                
                
                    Vulvar cancer is a rare disease in which malignant (cancer) cells form in the tissues of the vulva.
                    Vulvar cancer forms in a woman's external genitalia. The vulva includes:         - Inner and outer lips of the vagina.    - Clitoris (sensitive tissue between the lips).     - Opening of the vagina and its glands.    - Mons pubis (the rounded area in front of the pubic bones that becomes covered with hair at puberty).    -  Perineum (the area between the vulva and the anus).         Vulvar cancer most often affects the outer vaginal lips. Less often, cancer affects the inner vaginal lips, clitoris, or vaginal glands.    Vulvar cancer usually forms slowly over a number of years. Abnormal cells can grow on the surface of the vulvar skin for a long time. This condition is called vulvar intraepithelial neoplasia (VIN). Because it is possible for VIN to become vulvar cancer, it is very important to get treatment.
                
                
                    Having vulvar intraepithelial neoplasia or HPV infection can affect the risk of vulvar cancer.
                    Anything that increases your risk of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for vulvar cancer include the following:         - Having vulvar intraepithelial neoplasia (VIN).    - Having human papillomavirus (HPV) infection.    - Having a history of genital warts.        Other possible risk factors include the following:         - Having many sexual partners.    - Having first sexual intercourse at a young age.    - Having a history of abnormal Pap tests (Pap smears).
                          
                
							            Recurrent Vulvar Cancer
							            Recurrent vulvar cancer is cancer that has recurred (come back) after it has been treated. The cancer may come back in the vulva or in other parts of the body.

Topic: Vulvar Cancer
Source: CancerGov
Question: What are the symptoms of Vulvar Cancer ?
Answer: Signs of vulvar cancer include bleeding or itching. Vulvar cancer often does not cause early signs or symptoms. Signs and symptoms may be caused by vulvar cancer or by other conditions. Check with your doctor if you have any of the following:         - A lump or growth on the vulva.    - Changes in the vulvar skin, such as color changes or growths that look like a wart or ulcer.    - Itching in the vulvar area, that does not go away.    - Bleeding not related to menstruation (periods).    - Tenderness in the vulvar area.

Topic: Vulvar Cancer
Source: CancerGov
Question: How to diagnose Vulvar Cancer ?
Answer: Tests that examine the vulva are used to detect (find) and diagnose vulvar cancer. The following tests and procedures may be used:         -   Physical exam and history : An exam of the body to check general signs of health, including checking the vulva for signs of disease, such as lumps or anything else that seems unusual. A history of the patients health habits and past illnesses and treatments will also be taken.     -   Biopsy : The removal of samples of cells or tissues from the vulva so they can be viewed under a microscope by a pathologist to check for signs of cancer.

Topic: Vulvar Cancer
Source: CancerGov
Question: What is the outlook for Vulvar Cancer ?
Answer: Certain factors affect prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following:         - The stage of the cancer.    - The patient's age and general health.    - Whether the cancer has just been diagnosed or has recurred (come back).

Topic: Vulvar Cancer
Source: CancerGov
Question: what research (or clinical trials) is being done for Vulvar Cancer ?
Answer: New types of treatment are being tested in clinical trials.
                    Information about clinical trials is available from the NCI website.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.

Topic: Vulvar Cancer
Source: CancerGov
Question: What is (are) Gallbladder Cancer ?
Answer: Key Points
                    - Gallbladder cancer is a disease in which malignant (cancer) cells form in the tissues of the gallbladder.    - Being female can increase the risk of developing gallbladder cancer.     - Signs and symptoms of gallbladder cancer include jaundice, fever, and pain.     - Gallbladder cancer is difficult to detect (find) and diagnose early.     - Tests that examine the gallbladder and nearby organs are used to detect (find), diagnose, and stage gallbladder cancer.     - Certain factors affect the prognosis (chance of recovery) and treatment options.
                
                
                    Gallbladder cancer is a disease in which malignant (cancer) cells form in the tissues of the gallbladder.
                    Gallbladder cancer is a rare disease in which malignant (cancer) cells are found in the tissues of the gallbladder. The gallbladder is a pear-shaped organ that lies just under the liver in the upper abdomen. The gallbladder stores bile, a fluid made by the liver to digest fat. When food is being broken down in the stomach and intestines, bile is released from the gallbladder through a tube called the common bile duct, which connects the gallbladder and liver to the first part of the small intestine.      The wall of the gallbladder has 3 main layers of tissue.          -  Mucosal (inner) layer.    - Muscularis (middle, muscle) layer.     -  Serosal (outer) layer.        Between these layers is supporting connective tissue. Primary gallbladder cancer starts in the inner layer and spreads through the outer layers as it grows.
                
                
                    Gallbladder cancer is difficult to detect (find) and diagnose early.
                    Gallbladder cancer is difficult to detect and diagnose for the following reasons:         - There are no signs or symptoms in the early stages of gallbladder cancer.    - The symptoms of gallbladder cancer, when present, are like the symptoms of many other illnesses.    - The gallbladder is hidden behind the liver.         Gallbladder cancer is sometimes found when the gallbladder is removed for other reasons. Patients with gallstones rarely develop gallbladder cancer.

Topic: Gallbladder Cancer
Source: CancerGov
Question: Who is at risk for Gallbladder Cancer? ?
Answer: Being female can increase the risk of developing gallbladder cancer. Anything that increases your chance of getting a disease is called a risk factor. Having a risk factor does not mean that you will get cancer; not having risk factors doesn't mean that you will not get cancer. Talk with your doctor if you think you may be at risk. Risk factors for gallbladder cancer include the following:         - Being female.    - Being Native American.

Topic: Gallbladder Cancer
Source: CancerGov
Question: What are the symptoms of Gallbladder Cancer ?
Answer: Signs and symptoms of gallbladder cancer include jaundice, fever, and pain. These and other signs and symptoms may be caused by gallbladder cancer or by other conditions. Check with your doctor if you have any of the following:         -  Jaundice (yellowing of the skin and whites of the eyes).    - Pain above the stomach.    -  Fever.    -  Nausea and vomiting.    -  Bloating.    - Lumps in the abdomen.

Topic: Gallbladder Cancer
Source: CancerGov
Question: What is the outlook for Gallbladder Cancer ?
Answer: Certain factors affect the prognosis (chance of recovery) and treatment options. The prognosis (chance of recovery) and treatment options depend on the following:          - The stage of the cancer (whether the cancer has spread from the gallbladder to other places in the body).    - Whether the cancer can be completely removed by surgery.    - The type of gallbladder cancer (how the cancer cell looks under a microscope).    - Whether the cancer has just been diagnosed or has recurred (come back).        Treatment may also depend on the age and general health of the patient and whether the cancer is causing signs or symptoms.   Gallbladder cancer can be cured only if it is found before it has spread, when it can be removed by surgery. If the cancer has spread, palliative treatment can improve the patient's quality of life by controlling the symptoms and complications of this disease.   Taking part in one of the clinical trials being done to improve treatment should be considered. Information about ongoing clinical trials is available from the NCI website.

Topic: Gallbladder Cancer
Source: CancerGov
Question: what research (or clinical trials) is being done for Gallbladder Cancer ?
Answer: New types of treatment are being tested in clinical trials.
                    This summary section describes treatments that are being studied in clinical trials. It may not mention every new treatment being studied. Information about clinical trials is available from the NCI website.     Radiation sensitizers    Clinical trials are studying ways to improve the effect of radiation therapy on tumor cells, including the following:            -  Hyperthermia therapy: A treatment in which body tissue is exposed to high temperatures to damage and kill cancer cells or to make cancer cells more sensitive to the effects of radiation therapy and certain anticancer drugs.     -  Radiosensitizers: Drugs that make tumor cells more sensitive to radiation therapy. Giving radiation therapy together with radiosensitizers may kill more tumor cells.
                
                
                    Patients may want to think about taking part in a clinical trial.
                    For some patients, taking part in a clinical trial may be the best treatment choice. Clinical trials are part of the cancer research process. Clinical trials are done to find out if new cancer treatments are safe and effective or better than the standard treatment.   Many of today's standard treatments for cancer are based on earlier clinical trials. Patients who take part in a clinical trial may receive the standard treatment or be among the first to receive a new treatment.   Patients who take part in clinical trials also help improve the way cancer will be treated in the future. Even when clinical trials do not lead to effective new treatments, they often answer important questions and help move research forward.
                
                
                    Patients can enter clinical trials before, during, or after starting their cancer treatment.
                    Some clinical trials only include patients who have not yet received treatment. Other trials test treatments for patients whose cancer has not gotten better. There are also clinical trials that test new ways to stop cancer from recurring (coming back) or reduce the side effects of cancer treatment.   Clinical trials are taking place in many parts of the country. See the Treatment Options section that follows for links to current treatment clinical trials. These have been retrieved from NCI's listing of clinical trials.

Topic: Gallbladder Cancer
Source: CancerGov